Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer

Clinical trial NCT02043288 · COMPLETED

Trial details

NCT number: NCT02043288
Sponsor: Orient Europharma Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Neoplasms

Start date: 2014-01-01
Primary completion: 2019-12-01
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.